MetaCap

Alpha Tau Medical (DRTS) vs Kardigan (KARD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Alpha Tau Medical is the larger company by market cap ($1.32 billion vs $1.29 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DRTS+45.71%KARD-37.14%
+63%+10%-44%
Jun 18, 20261 yearOct 7, 2026
DRTS+45.71%KARD-37.14%
+60%+9%-42%
Jun 15, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DRTS versus KARD key metrics
MetricDRTSKARD
Share price$14.25$13.83
Market cap$1.32B$1.29B
1-day change-1.59%+2.52%
YTD return+187.88%—
1-year return+245.04%—
5-year return+44.08%—
EPS (TTM)$-1.04$-10.93
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$15.79$27.00
52-week low$3.43$12.32
Distance from 52-week high-9.75%-48.78%
Analyst consensusnonestrong_buy
Avg. price target upside+24.91%+205.50%
Average volume568.24K477.59K
Shares outstanding92.48M93.50M
Employees121241
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Alpha Tau Medical

DRTS stock →

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.

Healthcare · Biotechnology · 121 employees

About Kardigan

KARD stock →

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases.

Healthcare · Biotechnology · 241 employees

DRTS vs KARD FAQ

Which is bigger, Alpha Tau Medical or Kardigan?

Alpha Tau Medical (DRTS) is larger, with a market capitalization of $1.32B compared with $1.29B for Kardigan (KARD).

Are Alpha Tau Medical and Kardigan in the same industry?

Yes. Both are classified in the Biotechnology industry within the Healthcare sector.

More comparisons